A woman kneels to help a young girl with her coat in a softly lit, emergent entryway, where shoes and bags are scattered nearby and sunlight streams through the window and door in the background.

PREPAREDNESS TODAY, SAFER TOMORROW.

Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada

Emergent has announced a series of new contracts and a contract modification with the Public Health Agency of Canada (PHAC) and the Department of National Defence (DND) to deliver critical medical countermeasures to support Canada’s biological threat preparedness and response infrastructure.

LEARN MORE

The New Way Forward

Who we protect will not change, but how we protect them will. Emergent is leading the new way forward for public health.

Learn more

Capabilities

We are a leading public health company that delivers protective and life-saving solutions to communities around the world.

  • A simple illustration of a cardboard box with arrows pointing up, down, left, and right, indicating emergent movement or directions in all four directions. Commercial Products

    We offer commercialized products that address endemic public health threats such as the opioid epidemic.

  • A magnifying glass with a red pie chart segment inside, representing emergent data analysis or focusing on a specific portion of information. Medical Countermeasures

    We specialize in developing, manufacturing, and supplying medical countermeasures for national security and public health preparedness.

  • A simple, stylized illustration of a robotic arm with red accent areas, showing its jointed structure and gripper at the end, highlighting its emergent role in industrial automation. Strategic Partnerships

    We leverage our specialized in-house capabilities to support biopharma innovators, governments and non-government organizations with their development and manufacturing needs. ​

A man in a pink shirt looks up while standing next to a whiteboard covered in emergent blue and orange writing in a dimly-lit room.

At Emergent, our mission is to protect and save lives.

View our 2024 Annual Report

Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program

WINNIPEG, Manitoba, April 09, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced that it has partnered with the B.C. Provincial Health Services Authority (PHSA) to supply NARCAN® Nasal Spray for the province’s Take-Home Naloxone Program (BC THN Program).
Read More

Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures

GAITHERSBURG, Md., March 25, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured a contract award valued at approximately $54 million USD to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.
Read More

Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of John D. Fowler, Jr. to its board of directors effective March 1, 2026.
Read More
READ ALL NEWS